Polymerase Chain Reaction (PCR)
A prospective and diagnostic marker for the development of posttransplant lymphoproliferative disorders (PTLD), especially in Epstein-Barr virus (EBV)-seronegative organ transplant recipients who receive anti-lymphocyte globulin for induction immunosuppression and OKT-3 treatment for early rejection.
A single assay result should not be used as the only criteria to form a clinical conclusion. Results should be correlated with serologic test results, patient symptoms and clinical presentation.
1 - 3 days
- EBV Viral Load, Blood
Reportable range is 2,000 to 200,000,000 copies/mL. Test sent to Mayo Medical Laboratories.